0001062993-21-012695.txt : 20211210 0001062993-21-012695.hdr.sgml : 20211210 20211210185605 ACCESSION NUMBER: 0001062993-21-012695 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211208 FILED AS OF DATE: 20211210 DATE AS OF CHANGE: 20211210 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Smith Edward F CENTRAL INDEX KEY: 0001368350 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39267 FILM NUMBER: 211486596 MAIL ADDRESS: STREET 1: C/O POLYMEDIX, INC. STREET 2: 3701 MARKET STREET CITY: PHILADELPHIA STATE: PA ZIP: 19104 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Benitec Biopharma Inc. CENTRAL INDEX KEY: 0001808898 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 3940 TRUST WAY CITY: HAYWARD STATE: CA ZIP: 94545 BUSINESS PHONE: (510) 780-0819 MAIL ADDRESS: STREET 1: 3940 TRUST WAY CITY: HAYWARD STATE: CA ZIP: 94545 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0306 4 2021-12-08 0001808898 Benitec Biopharma Inc. BNTC 0001368350 Smith Edward F C/O BENITEC BIOPHARMA INC. 3940 TRUST WAY HAYWARD CA 94545 1 0 0 0 Options (right to buy) 2.99 2021-12-08 4 A 0 12000 0 A 2031-12-08 Common Stock 12000 12000 D The stock options will vest in three substantially equal installments on the day prior to each of the Issuer's next three annual stockholder meetings occurring immediately following the date of grant. /s/ Edward Smith 2021-12-10